fig1

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Figure 1. Summary of the different pathways involved in the anti-HCC activity of quercetin (created with BioRender.com). ↑: increase; ↓: decrease. HCC: Hepatocellular carcinoma; IGF-1: insulin-like growth factor 1; TNF-α: tumor necrosis factor-alfa; IL: interleukin; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; JAK/STAT3: Janus kinase/signal transducer and activator of transcription; IκBα: inhibitor of kappa B alpha; ROS: reactive oxygen species.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/